shutterstock_1715090101_mark_van_scyoc

Mark Van Scyoc / Shutterstock.com

7 February 2022Big PharmaAlex Baldwin

PhRMA says EU, WTO, others are ‘weakening’ IP

Pharmaceutical industry consortium PhRMA has asked the Office of the US Trade Representative (USTR) to put the European Union, the World Trade Organization (WTO) and the UK on a watch list of trading partners that could “weaken” IP rights.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

PhRMA shames Brazil and Thailand over patent backlogs

6 November 2018 Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

BIO and PhRMA file petition supporting Illumina

7 March 2017 Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.

More on this story

PhRMA shames Brazil and Thailand over patent backlogs

6 November 2018 Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

BIO and PhRMA file petition supporting Illumina

7 March 2017 Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.

More on this story

PhRMA shames Brazil and Thailand over patent backlogs

6 November 2018 Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

BIO and PhRMA file petition supporting Illumina

7 March 2017 Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.

More features

President Trump 2.0: Five major areas to watch

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?

Pfizer infringed haemophilia therapy patent, says court